[1]
|
M. Baggiolini, B. Dewald and B. Moser, “Human Chemokines: An Update,” Annual Review of Immunology, Vol. 15, 1997, pp. 675-705.
doi:10.1146/annurev.immunol.15.1.675
|
[2]
|
B. J. Rollins, “Chemokines,” Blood, Vol. 90, No. 3, 1997, pp. 909-928.
|
[3]
|
G. S. Kelner, J. Kennedy, K. B. Bacon, et al., “Lymphotactin: A Cytokine That Represents a New Class of Chemokines,” Science, Vol. 266, No. 5189, 1994, pp. 1395-1399. doi:10.1126/science.7973732
|
[4]
|
R. M. Ransohoff, “Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology,” Immunity, Vol. 31, No. 5, 2009, pp. 711-721. doi:10.1016/j.immuni.2009.09.010
|
[5]
|
A. Rot and U. H. von Andrian, “Chemokines in Innate and Adaptive Host Defense: Basic Chemokinese Grammar for Immune Cells,” Annual Review of Immunology, Vol. 22, No. 1, 2004, pp. 891-928.
doi:10.1146/annurev.immunol.22.012703.104543
|
[6]
|
G. Lazennec and A. Richmond, “Chemokines and Chemokine Receptors: New Insights into Cancer-Related Inflammation,” Trends in Molecular Medicine, Vol. 16, No. 3, pp. 133-144. doi:10.1016/j.molmed.2010.01.003
|
[7]
|
R. C. Kruizinga, J. Bestebroer, P. Berghuis, C. J. de Haas, T. P. Links, E. G. de Vries, et al., “Role of Chemokines and Their Receptors in Cancer,” Current Pharmaceutical Design, Vol. 15, No. 29, 2009, pp. 3396-3416.
doi:10.2174/138161209789105081
|
[8]
|
A. Zlotnik, “Chemokines and Cancer,” International Journal of Cancer, Vol. 119, No. 9, 2006, pp. 2026-2029.
doi:10.1002/ijc.22024
|
[9]
|
J. Kim, H. Takeuchi, S. T. Lam, R. R. Turner, H. J. Wang, C. Kuo, L. Foshag, A. J. Bilchik and D. S. Hoon, “Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival,” Journal of Clinical Oncology, Vol. 23, No. 12, 2005, pp. 2744-2753.
doi:10.1200/JCO.2005.07.078
|
[10]
|
C. C. Schimanski, P. R. Galle and M. Markus, “Chemokine Receptor CXCR4-Prognostic Factor for Gastrointestinal Tumors,” World Journal of Gastroenterology, Vol. 14, No. 30, 2008, pp. 4721-4724.
|
[11]
|
C. C. Schimanski, S. Schwald, N. Simiantonaki, C. Jayasinghe, U. Gonner, V. Wilsberg, T. Junginger, M. R. Berger, P. R. Galle and M. Moehler, “Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer,” Clinical Cancer Research, Vol. 11, No. 5, 2005, pp. 1743-1750.
doi:10.1158/1078-0432.CCR-04-1195
|
[12]
|
Y. Lou, J. Cai, H. Xue, et al., “Functional SDF1 Alpha/CXCR4 Signaling in the Developing Spinal Cord,” Journal of Neurochemistry, Vol. 93, No. 2, 2005, pp. 452-462. doi:10.1111/j.1471-4159.2005.03049.x
|